Skip to main content
Premium Trial:

Request an Annual Quote

Epitome Nets $500K SBIR Grant to Develop Protein Phosphorylation Arrays

NEW YORK (GenomeWeb News) — Epitome Biosystems has received a $500,000 Phase IIB Small Business Innovation Research grant from the National Science foundation, the company said today.
Epitome will use the cash to help it develop a technology that measures ”key tyrosine phosphorylation sites that have important roles in many cellular and drug responses,” the company said.
The technology is an antibody array that incorporates Epitome's EpiTag platform to enable researchers to qualitatively and quantitatively measure protein phosphorylation.
The firm won a Phase II SBIR grant, also for $500,000, in October 2005 that it used to develop a protein kinase that profiles cell-signaling pathways.

President Neal Gordon said the company’s products may help pharmas to develop drugs targeting diseases with abnormal signaling, such as kinase inhibitors.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.